| KIRIN BEER KABUSHIKI KAISHA Patent applications |
| Patent application number | Title | Published |
|---|
| 20120121790 | ALCOHOL-FREE BEER-LIKE MALT BEVERAGE AND METHOD FOR PRODUCING SAME - Provided is an alcohol-free beer-like malt beverage from wort added with hop component without fermentation, having reduced off-flavor intrinsic to a malt beverage and suppressed nasty smell derived from hop, and retaining an aromatic component of hop. Produced is an alcohol-free beer-like malt beverage having reduced off-flavor and retaining an aromatic component of hop without fermentation, unlike a conventional non-alcohol beer production process, by controlling the content of a hop-derived aromatic component, myrcene, α-humulene or β-selinene, in the beer-like malt beverage to a specific value. In the present invention, the content of a hop-derived aromatic component in the beer-like malt beverage is controlled by controlling the addition timing or additive amount of hop and/or a hop essential-oil component during a wort-boiling step or the addition amount of a hop essential-oil component in a step after the wort-boiling step. | 05-17-2012 |
| 20120021110 | FLAVOR OF UNFERMENTED BEER-FLAVORED MALT BEVERAGE - A method for producing an unfermented beer-flavored malt beverage according to the present invention comprises adjusting linalool and acetaldehyde concentrations in a malt beverage to be improved in flavor to thereby impart or enhance a fermentation flavor in the beverage. The present invention also relates to a malt beverage having an improved flavor and a flavor improving agent. According to the present invention, a well-balanced fermentation flavor can be imparted or enhanced in an unfermented beer-flavored malt beverage to thereby improve the flavor of the beverage. | 01-26-2012 |
| 20110105747 | QUINOLINE DERIVATIVE AND QUINAZOLINE DERIVATIVE INHIBITING SELF-PHOSPHORYLATION OF HEPATOCYTUS PROLIFERATOR RECEPTOR, AND MEDICINAL COMPOSITION CONTAINING THE SAME - An objective of the present invention is to provide compounds having potent antitumor activity. The compounds of the present invention are represented by formula (I) or a pharmaceutically acceptable salt or solvate thereof: | 05-05-2011 |
| 20100326281 | EASY-OPEN CAN END, METHOD FOR MANUFACTURING CAN END, AND BEVERAGE PRODUCT FILLED IN CAN CONTAINER USING THE SAME - An easy-open can end including an inclined surface formed in a direction of a tab tail of a pull-tab from a center of a panel such that the center of the panel becomes a maximum concave portion, a lower surface of the pull-tab abuts on the inclined surface or is brought close to the inclined surface along the inclined surface, the pull-tab has a pit S formed by pressing-down forming, and the pull-tab is bent by the pit S. A method for manufacturing an easy-open can end including a process for pressing down part of an outer rim of the pull-tab after or at the same time as a process for fixing the pull-tab to the panel. | 12-30-2010 |
| 20100275847 | DLC FILM COATED PLASTIC CONTAINER, AND DEVICE AND METHOD FOR MANUFACTURING THE PLASTIC CONTAINER - The present invention provides a plastic container having a inner wall surface coated with DLC film which has same level of oxygen barrier property as prior art and can prevent a coloring of the DLC film formed on a neck portion of the container, manufacturing apparatus therefor and manufacturing method thereof. | 11-04-2010 |
| 20100216127 | PRIMER SET FOR USE IN DETECTION OF YEAST OF GENUS SACCHAROMYCES - An object of the present invention is to provide a primer set, which can accurately, rapidly and simply identify yeast species of genus | 08-26-2010 |
| 20100096393 | BARRIER-FILM FORMING APPARATUS, BARRIER-FILM FORMING METHOD, AND BARRIER-FILM COATED CONTAINER - A barrier-film forming apparatus that forms a barrier film on an inner face of a container ( | 04-22-2010 |
| 20100047781 | PRIMER SET FOR DETECTION OF DEKKERA YEAST OR BRETTANOMYCES YEAST - An object of the present invention is to provide a primer set for use in a LAMP method, which can accurately, rapidly and simply identify yeast species of genus | 02-25-2010 |
| 20100009030 | METHOD OF IMPROVING FERMENTABILITY OF EARLY FLOCCULATING MALT - It is to provide a method that enables manufacture of beer or HAPPOSHU with good fermentation with yeast and having rich flavor, by improving the fermentability of premature yeast flocculation malt (PYF malt) (malt comprising factors causing early flocculation of yeast) even when PYF malt is used in the manufacture of beer or HAPPOSHU. In the manufacture of beer or HAPPOSHU using premature yeast flocculation malt (PYF malt), tannic acid is added and treated to wort and/or yeast used for fermentation, to improve the fermentability of premature yeast flocculation malt. In the present invention, in order to improve fermentability of early flocculatin malt, tannic acid is added and treated to wort before addition of yeast or to wort fermentation solution after adding yeast, or to yeast for adding to wort, in the manufacturing step of beer or HAPPOSHU. Preferred tannic acids used in the present invention include gallotannin, tara-tannin, gallic tannin (hydrolysable tannin) and persimmon tannin (condensed tannin). | 01-14-2010 |
| 20090312313 | COMPOUND HAVING TGFBETA INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME - The present invention provides compounds represented by formula (I) and pharmaceutically acceptable salts and solvates thereof: | 12-17-2009 |
| 20090263792 | ATOPIC DERMATITIS MARKER AND TECHNIQUE OF USING THE SAME - It is an object of the present invention to find substances that can be used as disease markers for atopic dermatitis and the present invention provides a method for determining atopic dermatitis, including measurement of the expression of specific proteins and/or their genes in skin cells and/or skin tissues, wherein the specific proteins change their expression with inflammation caused by atopic dermatitis or change their expression according to the degree of predisposition to atopic dermatitis. The present invention also provides a kit for determining the degree of inflammation of atopic dermatitis or risk of developing atopic dermatitis, as well as a method for determining substances effective in the treatment and/or prevention of atopic dermatitis. | 10-22-2009 |
| 20090196872 | HUMAN MONOCLONAL ANTIBODIES TO INFLUENZA M2 PROTEIN AND METHODS OF MAKING AND USING SAME - Human, humanized and chimeric monoclonal antibodies that bind to influenza M2 protein. A human monoclonal antibody that binds to influenza M2 protein having different amino acid sequences. The antibodies are useful for, among other things, treatment, diagnostics, purifying and isolating M2 or influenza virus, and identifying the presence of M2 or influenza virus in a sample or a subject. | 08-06-2009 |
| 20090176993 | Calcium receptor active compounds - A novel calcium receptor active compound having the formula is provided: | 07-09-2009 |
| 20090120556 | Method For Producing Hermetically Sealed Container For Beverage Or Food - An object of the present invention is to provide a method for producing a hermetically sealed container, which method comprises conducting hermetic sealing of a container for beverage or food using a laser welding method, whereby the process speed of the sealing process can be made fast, strict control of the scanning position of laser spots is unnecessary, partial oversupply of energy does not occur easily, and there is no reduction in the welding area or welding strength per area due to the gathering of water drops. | 05-14-2009 |
| 20090084156 | METHOD FOR MEASURING OXYGEN AMOUNT IN HERMETICALLY SEALED CONTAINER AND PIERCING DEVICE FOR HERMETICALLY SEALED CONTAINER USED THEREFORE - An object is to offer a method that can efficiently measure the oxygen content of both the headspace and fluid within a hermetically sealed container by taking advantage of the characteristics of a fluorescent-type oxygen concentration meter. | 04-02-2009 |
| 20090081221 | METHOD FOR SUPPRESSING CANCER CELL METASTASIS AND PHARMACEUTICAL COMPOSITION FOR USE IN THE METHOD - The present invention provides a novel method for inhibiting cancer cell metastasis using an antibody against TM7XN1, a pharmaceutical composition to be used for the method, and a cancer-metastasis-suppressing agent comprising an antibody against TM7XN1 as an active ingredient. | 03-26-2009 |
| 20090068702 | METHOD FOR PRODUCING A MUCIN-TYPE GLYCOPROTEIN - The present invention relates to a means for generating a mucin-type glycopeptide or glycoprotein on a large scale in yeast. Specifically, the invention relates to a method which comprises introducing into a yeast at least one selected from the group consisting of a gene encoding UDP-GalNAc synthetase, a gene encoding UDP-GalNAc transporter, and a gene encoding polypeptide:O-GalNAc transferase, and, if desired, a gene encoding a mucin-type glycopeptide; and producing a mucin-type glycoprotein having O-GalNAc by use of the yeast. | 03-12-2009 |
| 20090061111 | APPARATUS FOR MANUFACTURING GAS BARRIER PLASTIC CONTAINER, METHOD FOR MANUFACTURING THE CONTAINER, AND THE CONTAINER - The object of the present invention is to provide an apparatus for manufacturing a gas barrier plastic container which simultaneously satisfies the condition that the same vacuum chamber can be used even when the container shapes are different, the condition that a high-frequency power source is unnecessary, and the condition that film formation can be carried out for a plurality of containers inside one vacuum chamber in order to make the apparatus low cost. In an apparatus for forming a film on the inner surface of a container, a thermal catalyst is supported on a source gas supply pipe, and the source gas supply pipe is inserted into the port of the container, followed by film formation. In an apparatus for forming a film on the outer surface of a container, a thermal catalyst is arranged on the periphery of the plastic, and a source gas is blown out through the source gas supply pipe while bringing the source gas into contact with the thermal catalyst for film formation. Cooling is carried out to avoid the thermal deformation of the container by heat radiated from the thermal catalyst. For example, a container on which a hydrogen-containing SiN | 03-05-2009 |
| 20080312221 | QUINOLINE DERIVATIVE AND QUINAZOLINE DERIVATIVE INHIBITING SELF-PHOSPHORYLATION OF HEPATOCYTUS PROLIFERATOR RECEPTOR, AND MEDICINAL COMPOSITION CONTAINING THE SAME - An objective of the present invention is to provide compounds having potent antitumor activity. The compounds of the present invention are represented by formula (I) or a pharmaceutically acceptable salt or solvate thereof: | 12-18-2008 |
| 20080311155 | Strain-Independent Amplification of Pathogens and Vaccines Thereto - This in invention relates to methods for the nucleic acid amplification of multiple variants (strains) of any pathogen present in a sample, and preferably in a sample from a pathogen infected individual. In preferred embodiments, the pathogen is a retrovirus, such as HIV. The amplified pathogen nucleic acid can be used to identify the pathogen variants present in a sample, to quantitate the pathogen present in a sample, and as a nucleic acid vaccine, or in the preparation of antigen presenting cell vaccines. Nucleic acids produced by the methods of the invention or the proteins encoded thereby can be used to transfect/load antigen presenting cells. The loaded antigen presenting cells can then be used as a vaccine for the treatment of pathogen infection. In another embodiment, nucleic acids produced by the methods of the invention can be used directly as nucleic acid vaccines without prior loading into antigen presenting cells. | 12-18-2008 |
| 20080207617 | Quinoline Derivatives and Quinazoline Derivatives Inhibiting Autophosphrylation of Flt3 and Medicinal Compositions Containing the Same - An objective of the present invention is to provide compounds and pharmaceuticals useful for the treatment of disease where the inhibition of autophosphorylation of FMS-like tyrosine kinase 3(Flt3) is therapeutically effective. The present invention relates to a pharmaceutical composition for use in the treatment or prevention of diseases where the inhibition of autophosphorylation of Flt3 therapeutically or prophylactically effective, which comprises a compound represented by formula (I) or a pharmaceutically acceptable salt or solvate thereof: | 08-28-2008 |
